Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein - PubMed (original) (raw)

. 1993 Jan 15;53(2):310-7.

Affiliations

PMID: 7678072

Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein

R J Arceci et al. Cancer Res. 1993.

Abstract

A membrane glycoprotein, termed P-glycoprotein, has been shown to be responsible for cross-resistance to a broad range of structurally and functionally distinct cytotoxic agents. P-glycoprotein, encoded in humans by the mdr1 gene, functions as an energy-dependent efflux pump to exclude these cytotoxic agents from the resistant cell. In order to study the phenomenon of multidrug resistance in both normal and neoplastic cells, we have generated a mouse monoclonal antibody directed to an external epitope of the human P-glycoprotein. This monoclonal antibody, 4E3, is an IgG2a class antibody which specifically recognizes the human mdr1 P-glycoprotein but not the mdr3 gene product. The 4E3 monoclonal antibody immunoprecipitates both the glycosylated and nonglycosylated forms of P-glycoprotein under mild denaturation conditions. In addition, 4E3 can detect P-glycoprotein in immunocytochemical analysis of fixed tissue-cultured cells and in analysis of frozen sections of human tissue. Binding of the monoclonal antibody to multidrug-resistant cells does not significantly affect the intracellular accumulation or potentiate the cytotoxicity of daunomycin in multidrug-resistant cells. However, at high concentrations of antibody, 4E3 produces a mild potentiation of vinblastine and actinomycin cytotoxicity in multidrug-resistant cells. This monoclonal antibody will be useful both for analyzing P-glycoprotein expression in normal and neoplastic cells and for isolating live cells expressing the P-glycoprotein without significantly affecting the efflux functions of the transporter.

PubMed Disclaimer

Cited by

Detection of recombinant P-glycoprotein in multidrug resistant cultured cells.
Germann UA. Germann UA. Mol Biotechnol. 2000 Feb;14(2):131-45. doi: 10.1385/MB:14:2:131. Mol Biotechnol. 2000. PMID: 10872505
Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.
Chiampanichayakul S, Anuchapreeda S, Chruewkamlow N, Mahasongkram K, Thanaratanakorn P, Kasinrerk W. Chiampanichayakul S, et al. Int J Hematol. 2010 Sep;92(2):326-33. doi: 10.1007/s12185-010-0668-8. Epub 2010 Aug 26. Int J Hematol. 2010. PMID: 20740331
Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.
Kiehntopf M, Brach MA, Licht T, Petschauer S, Karawajew L, Kirschning C, Herrmann F. Kiehntopf M, et al. EMBO J. 1994 Oct 3;13(19):4645-52. doi: 10.1002/j.1460-2075.1994.tb06787.x. EMBO J. 1994. PMID: 7925305 Free PMC article. Retracted.
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.
Randolph GJ, Beaulieu S, Pope M, Sugawara I, Hoffman L, Steinman RM, Muller WA. Randolph GJ, et al. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6924-9. doi: 10.1073/pnas.95.12.6924. Proc Natl Acad Sci U S A. 1998. PMID: 9618515 Free PMC article.
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Nüssler V, Pelka-Fleischer R, Zwierzina H, Nerl C, Beckert B, Gullis E, Gieseler F, Bock S, Bartl R, Petrides PE, et al. Nüssler V, et al. Ann Hematol. 1994;69 Suppl 1:S25-9. doi: 10.1007/BF01757351. Ann Hematol. 1994. PMID: 7914749

Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein - PubMed (original) (raw)